Tada M, Matsumoto Y, Koike T, Mamoto K, et al. Biological/targeted synthetic disease-modifying antirheumatic drugs improve not
only muscle mass but also phase angle in patients with rheumatoid arthritis. Clin Rheumatol 2025 Oct 31. doi: 10.1007/s10067-025-07767.
PMID: 41168624
|